Flerie invests in life science companies globally, leveraging its operational experience, broad networks, and access to top biotech/pharma ecosystems. It focuses on accelerating portfolio companies through active ownership, supporting product development and commercialization to address unmet medical needs and improve health outcomes. The firm syndicates with investors worldwide to build scalable companies in drug development, biologics, and adjacent spaces.
Bevorzugte Reifephase für die erste Finanzierung.
Pioneering pharmaceutical and biotech projects with unmet medical needs, including immuno-oncology, metabolic diseases, and drug development
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
